NexusBioTox was selected among the top 10 startups of the Porto Digital 2026.1 Incubation Program, the largest innovation district in Brazil. The achievement reinforces the strength of the company's approach, based on alternative preclinical toxicology models (zebrafish, Drosophila melanogaster, and Artemia salina) with OECD-certified methodologies.
To learn more about the journey and next steps, check out the full post by Dr. Jerusa Oliveira, CEO of NexusBioTox, on LinkedIn: Click here
